Primary open angle glaucoma is a leading cause of blindness in the United States. It is estimated that more than 2 million Americans have glaucoma and that 80,000 are legally blind from the disease. Currently, there is no uniform definition of glaucoma, particularly in the earliest stages of the disease. Glaucoma is diagnosed by identifying structural damage (characteristic optic nerve damage) or functional damage (characteristic visual field loss). Most glaucoma patients also have high intraocular pressure, a major risk factor for the disease. Defects in the retinal nerve fiber layer (RNFL) are an early sign of glaucoma. In some subjects, RNFL defects can be detected before changes in the optic nerve head 1 or visual field 22,29,32 are identified. Retinal ganglion cell atrophy cannot be visualized with clinical examinations, but can be detected indirectly as diffuse or focal RNFL defects. In diffuse loss, retinal vessels, which are embedded within the RNFL, may become clearer as retinal ganglion cell dropout increases focally with progressive glaucoma. In focal loss, a wedge-shaped defect widens with increasing distance from the disc margin. Delineation of early structural change in the peripapillary retinal nerve fibers might facilitate their diagnosis and improve the monitoring of progressive glaucomatous damage. Unfortunately, RNFL defects can be difficult to identify during clinical examination. Photographic documentation of the RNFL is often hard to obtain and is only routine at a few academic centers. In addition, photographic methods require full dilation and qualitative review at the patient's next clinic visit. Three new diagnostic instruments, the Heidelberg Retina Tomograph (Heidelberg Engineering, Heidelberg, Germany), the Nerve Fiber Analyzer II (Laser Diagnostics Technology, San Diego, CA), and the Optical Coherence Tomograph (OCT; Humphrey Instruments, San Leandro, CA) have the ability to provide real-time quantitative and objective assessments of the RNFL in vivo. Each of these instruments is based on different optical principles. The clinical use of an instrument depends on the reproducibility and accuracy of the results, and its ability to differentiate between normal and glaucoma eyes and to monitor disease progression. This article summarizes the current literature addressing each of these topics and compares RNFL measurements using these three instruments in normal, glaucoma, and glaucoma suspect eyes.